Page 1

Sacrificing Salary

to Save Lives Early cancer detection services

Affordable Unique Award-winning

Probably the most important benefit choice an employee can make


Welcome

Index

O

ver the last decade, healthcare services have figured highly in all employee surveys. Employees are seriously interested in topping up on the excellent NHS services already being provided. Originally, the services provided focused around 'reactive' services such as cash back plans and later on private medical insurance. Over the last 2 decades the appearance of 'full body MOTs' has been introduced as the first 'pro-active' service and enjoyed much attention.

Macmillan is forecasting 48% of all Britons will attract cancer over their lifetime by 2020. The NHS has also identified that 13,000 men and women die every year from work-related cancer and Department of Health is asking employers for help to fight the massive cancer burden. Is now the time to step-up the corporate fight against cancer? An increasing number of employers have identified the advantageous tax benefits in offering services like the ones highlighted in this magazine. Tax and NI can be deducted for employees and employers will benefit from not paying NI on the services. Some companies have decided that there are system benefits in offering the services as company paid benefits.

Welcome

2

In 2013 Employee Benefits awarded a Check4Cancer client the winner of the Healthcare and Wellness category with the words:

Our team

3

“The approach Hewlett-Packard took, in terms of the combination of screening and education, was impactful and gave a legacy to what it is doing. It was very different from the other entries – it fundamentally made a difference to employees’ lives.” Cancer has reached epidemic levels and NHS has limited resources to help with early detection and most private healthcare plans will not cover early detection. This is where Check4Cancer comes in; we do care, and we have services covering 85% of all new cancer incidence p.a. in the UK. HMRC pays for up to 50% of the cost and provides NI relief to employers.

Identifying cancer early will save lives. Troels Jordansen Managing Director

Prof Gordon Wishart Medical Director

The hard facts

4-5

Awareness Services

6-7

BowelCheck

8

BreastCheck

9

GynaeCheck & GynaeCheck+

10

LungCheck

11

ProstateCheck

12

SkinCheck & SkinCheck +

13

Who We Work With

14

Case study

15-17

Client satisfaction

18-19

Employees at increased risk 20-22 Payment options and pricing 2

23


Our team All the services offered by Check4Cancer are governed by nationally renowned specialist consultants

Mr Justin Davies

Clinical Advisor – Bowel

Justin Davies is a Consultant Colorectal Surgeon at Addenbrooke’s Hospital, Cambridge, where he is also Clinical Director of General Surgery. He has a strong research pedigree in bowel cancer screening, publishing his work in this field in high impact factor journals such as the Lancet and Nature Reviews Cancer. He is the recipient of several prestigious research prizes, including the Patey Prize and John of Arderne Medal, and has lectured on this topic nationally and internationally. He is a Member of Council of The Royal Society of Medicine Section of Coloproctology and is the current Chair of the Education and Training Committee of the Association of Coloproctology of Great Britain and Ireland. Justin joined BowelHealth UK in July 2013 as Clinical Director.

Prof. Gordon C. Wishart Clinical Advisor – Breast

Professor Wishart has an international reputation in the screening, diagnosis and treatment of breast cancer and his research is widely published in well respected clinical journals. As a Professor of Cancer Surgery, Professor Wishart has an interest in new tests or technologies for the early detection of common cancers. He set up BreastHealth UK to provide an innovative approach to private breast screening in the UK.

Jullien Brady

Clinical Advisor – Gynaecology

Jullien Brady has extensive experience in the UK cervical screening program. He is one of the National Quality Assurance Directors and Lead Colposcopist representing the East of England for both of these roles. He is also a member of the Executive Committee of the BSCCP, the governing body of Colposcopy. Mr Brady is passionate about women having the opportunity to maximise their health choices and screening options. Having done all his undergraduate and post graduate training in London Mr Brady was appointed as a Consultant in 2008. He also provides a comprehensive clinical service in Gynaecology.

Mr Aman Coonar Clinical Advisor – Lung

Mr Coonar has been a consultant at Papworth Hospital since 2007 and his practice is in pure thoracic surgery. He works closely with a large team including other surgeons, specialist nurses, radiologists and physicians. He was appointed President of the Royal Society of Medicine Cardiothoracic Section in December 2013 and has published several research papers and book chapters, some of which have received awards.

Mr Vincent Gnanapragasam Clinical Advisor – Prostate

Mr Vincent Gnanapragasam is an academic consultant urological surgeon at the University of Cambridge and Addenbrookes Hospital, Cambridge. He has trained in the Northern Deanery, Paris and Cambridge. He was the first urologist and surgeon to be awarded a Cancer Research UK Clinician Scientist Fellowship and is a recipient of a Hunterian Professorship from the Royal College of Surgeons of England. His academic work covers basic science, translational and clinical prostate cancer research with over 15 years of experience. His primary interests are in precision diagnostics, optimal management of high-risk prostate cancer and the use of biomarkers for personalised risk stratification and therapy selection. He has published over 55 scientific papers (84% as first or senior author).

Mr Per Hall

Clinical Advisor – Skin

Appointed Consultant Plastic Surgeon in Cambridge in 1995, Mr Per Hall has extensive experience in most plastic surgical applications. Over the last 20+ years he has been pioneering the early detection of skin cancer using computer imaging. Per Hall is also committed to training surgeons in cleft lip and palate surgery to provide care for children in developing countries. He oversees Check4Cancer’s SkinCheck service.

Dr Bernadette McKenna

Clinical Advisor – General Medical Services

Bernadette’s background is in general practice having worked as a GP with both individual clients and large corporate organisations for over a decade. She is passionate about health promotion and empowering patients to take control of their health. Combining a career in media with medicine she is ideally positioned to communicate key health messages to the public.

3


The hard facts

1lung7cancer

325,000

UK

in

cancer every year in the

people get

160,000

people die of cancer in the

UK every year

1 2 out of

1960

50% cancer survive

Around

will get cancer

time

40,000 diagnosed cancer UK Bowel second deaths UK Over

will

the odds

cancer is the in the

early

cancers occur in women with no family history of it

with

each year in the

and

increase significantly if

80%

men are

cancer

of people with

is detected

born after

most common cause of

never smoked

have

cancer

Britons

during their life

people who develop

2040

of breast

1million women over 65 By

more than

will be living with

breast cancer

The majority of people with the early stages of lung cancer have no apparent symptoms. Skin cancer is one of the most common cancers affecting both men and women.

Early detection 4

saves lives


Make a difference Duty of care is serious business – and we know that the health and happiness of employees can have a serious impact on your business or organisation, too. But it’s not just about helping businesses and organisations to function smoothly – it’s about saving lives. This is why more and more employers who care are introducing Check4Cancer services to their flexible benefits programme. Help your colleagues take control of their health by offering them early detection for the most common cancers. We have over 80 clinics available nationwide, and are led by some of the world’s leading experts.

The Department of Health has asked for support of employers in the early detection of all cancers including bowel cancer in its national plan ‘Improving Outcomes’.

Make a difference

More and more employers who care are introducing Check4Cancer services to their flexible benefits programme. Help your colleagues take control of their health by offering them early detection for the most common cancers. We have over 80 clinics available nationwide.

✓ ✓ ✓

Affordable – available from as little as £5 per month* under a salary sacrifice scheme

Unique – not available through any other provider in the UK, our personalised early detection services save lives

Award-winning – our distinctive services have won 2 major prices in 2013 and 2014. Check out www.Check4Cacner.com/awards

*£5 per month is based on a service valued at £100 less 40% income tax and 2% NI with the cost split over 12 months

To enquire 0800 085 6663

Info@Check4Cancer.com

www.Check4Cancer.com 5


Innovative solutions for cancer detection and awareness in the workplace As professionals in the healthcare sector, we recognise that cancer and the consequences of cancer are having a dramatic affect upon many people, their families and employers. Loss of life, time off work and increasing healthcare costs are just some of the measurable issues, as well as the emotional impact cancer brings such as fear, risk and concerns about detecting and treating cancer early enough to ensure a positive outcome. At Check4Cancer we focus on the early detection of cancer because, quite simply, it saves lives. Our personalised cancer

What people do not know, they cannot react to. By providing awareness of cancer, we hope that people may become empowered to self-diagnose and thereby save lives. Check4Cancer has taken advice from leading national clinicians to ensure the highest possible quality of information and by using experienced clinical staff with good presentation skills, we believe our services are second to none.

Prof Gordon Wishart, Medical Director, Check4Cancer

screening services – established and guided by world-leading clinicians – can also help reduce the significant financial and emotional costs of such illnesses. Specialist screening services available include BowelCheck, BreastCheck, GynaeCheck, LungCheck, ProstateCheck and SkinCheck – all outlined in the following pages. We also offer innovative awareness services to aid the understanding of symptoms and recognise when there may be a problem – knowledge which, in itself, can help save lives.

Raising awareness –

the power of knowledge Specialists in awareness and early detection of the most common cancers, Check4Cancer has educated thousands of employees to identify their risk and become their best line of defence. Check4Cancer can deliver a range of services, which can be customised to meet an organisation’s individual needs.

Presentations Probably our most popular awareness tool. Check4Cancer can provide presentations for the most common cancers, delivered by clinicians with significant experience and understanding of the cancer in focus. Presentations generally last around 40 minutes including 20 minutes for questions and answers. Where possible – for example, with breast cancer – the clinician will use a model to explain self examination and the difference between normal and abnormal lumps. All delegates receive a hard copy of the presentation and the supporting information leaflet.

6

The optimal number of delegates is 20 to 40 and some sessions benefit from being made available to one sex only.


Web resources Check4Cancer also offers online awareness platforms, ranging from a small website covering one cancer to larger international and multi-lingual websites covering several cancers. Having worked with international organisations over a number of years we are experienced providers of:

campaign the correct answers to the online questionnaire increased from 67% to 83% – a clear indication that the campaign had proved effective.

Info-stands

• Web content covering the most common cancers • Animations • Cancer specific videos and online presentations (including live webcasts) • Frequently asked question videos • Online questionnaires providing measurable outcomes of awareness campaigns • Participation activities such as ‘Memory Wall’ or ‘Personal Stories’

Online cancer quiz Some organisations opt to use our cancer quiz to help employees assess their own cancer knowledge. This online questionnaire is ideally completed both before and after the campaign. In one such

Info-stand created for skin cancer For companies where internet access is not so widely available, it may sometimes prove more effective to provide an information display. Placed in the company dining area or other communal space, these stands are generally produced for awareness of one cancer campaign at a time. They can also include a testing element, such as a skin app for a tablet computer where the user can test his or her understanding of skin cancer using information offered at the info-stand.

Booklets

Skin app for tablet computer

We have had over 3,000 people undertake ProstateCheck and 3,000 people also undertook SkinCheck and from there a number of cancer cases were confirmed, so this screening was a real health benefit to our employees. Even those who didn’t have a cancer confirmed they felt that learning more about it was of real benefit.

Mark Osborn, UK&I Total Rewards, Hewlett-Packard

Where employees are spread over a large geographical area or seldom visit an office, Check4Cancer can produce single or multiple cancer booklets. The booklets can be designed to fit a specific corporate image, be co-branded and made available in any desired language or format. They offer a traditional, effective and cost efficient solution.

About Check4Cancer All services from Check4Cancer are reviewed and approved by a group of Clinical Advisors. They can be viewed at our website www.check4cancer.com/about This means that you can rest assured all information provided is not only useful and educational, but also accurate and up to date. Check4Cancer can provide services throughout the UK with 4-6 weeks notice and overseas with 8 weeks notice. International projects will be delivered by local clinicians in the local language.

To enquire 0800 085 6663

Info@Check4Cancer.com

www.Check4Cancer.com 7


Nearly 41,000 men and women are diagnosed with bowel cancer each year in the UK This year alone over 16,000 patients will die of bowel cancer, making it the second most common cause of cancer deaths in the UK. However, around 90% of all bowel cancers that are detected early enough are successfully treated, which means the benefits of early detection can be life changing.

BowelCheck Bowel Health Awareness We can deliver a 40 minute presentation plus questions by an experienced clinician focused on bowel cancer and covering symptoms, risk-reducing steps and treatment options. A copy of the presentation and My Bowel Health brochure will be available as handouts. Optimal group size is up to 40. BowelHealth UK can also provide copy material for client intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can be co-branded.

While the NHS runs a screening programme for people aged 60+ (Scotland aged 50+), the technology used is somewhat outdated and has a low uptake. BowelCheck incorporates the latest immunohistochemistry technology which is more sensitive and can be carried out in the comfort and privacy of the home.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard pricing. A typical taxpayer will pay around £4 per month under salary sacrifice. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service offering.

BowelCheck Procedure Upon sign-up the BowelCheck testing kit is sent out in the post. The kit contains full, simple instructions and a pre-paid return envelope. It will be returned to our laboratory and results are provided within 1-2 weeks. Within 1-2 weeks of returning the tests, employees will receive their results letter and a personalised early detection programme. If their results show that they are considered to be at high risk they will be referred to a consultant for further investigation.

Who will benefit

• BowelCheck is suitable for men and women over 45 • All men and women will benefit from greater understanding • People with a family history of bowel cancer

To enquire 0800 085 6663 8

Info@Check4Cancer.com

www.Check4Cancer.com


1 in 8 women will get breast cancer in their lifetime. Nearly 50,000 breast cancers are identified every year in the UK and it is now the most common cause of death in women younger than 35. But, contrary to popular belief, 80% of women with breast cancer have no family history. Breast cancer also affects men. For every 100 women, 1 man will also be diagnosed with breast cancer.

BreastCheck If on-site clinics are not available, BreastHealth UK will be able to access fit-for-purpose private clinics from more than 80 in our network throughout the United Kingdom and other countries upon request.

Breast Health Awareness The good news is that breast cancer can be successfully treated if detected early enough – and life expectancy is steadily increasing. In the UK, all women over the age of 50 are offered a mammogram every 3rd year by the NHS. BreastCheck offers not only screening for both women and men, but information and awareness of breast health issues that put employees in control of their own breast health.

BreastCheck procedure BreastCheck includes risk assessment, a 20 minute consultation with a specialist breast nurse, clinical breast examination and tuition in breast awareness. Monthly breast aware reminders are also provided at the right time of the month. Results will be explained during the consultation and employees will receive a written report and personalised breast cancer early detection programme within 5 days of the consultation. Mobile mammography is available to larger companies and all clients can also access mammography in private clinics.

Clinic locations On-site clinics are generally the most cost effective solution. We will require:

• Access to the internet • Couch • Wash hand basin

We can deliver a 40 minute presentation plus questions focused on breast cancer covering symptoms, self-awareness, riskreducing steps and treatment options. A copy of the presentation and My Breast Health brochures will be available as handouts. Optimal group size is up to 40. BreastHealth UK can provide copy material for client intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can be co-branded.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard pricing. A typical taxpayer will pay around £6 per month under salary sacrifice. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service offering.

Who will benefit

• All ages. It is never too early to know the symptoms of breast cancer, how to selfexamine and how to identify changes in the breast. • BreastCheck is suitable for men and women

To enquire 0800 085 6663

Info@Check4Cancer.com

www.Check4Cancer.com 9


Cervical cancer is the most common cancer in women under 35 in the UK Each year nearly 2,900 women – 8 women per day – will be diagnosed with cervical cancer in the UK. This is 11 women each working day. If cervical cancer is detected early, 90% of these women will survive with minimum lifestyle changes.

GynaeCheck their results letter and personalised early detection programme. If their results show that they are considered to be at high risk they will be referred for further investigation.

Cervical Health Awareness

GynaeCheck provides a method for detection of HPV virus which is responsible for the vast majority of all cervical cancers. In England all women over 25 (in Scotland all women over 20) are offered cervical cancer screening every 3rd year and from age 50, only every 5th year. However, only 2 in 3 young women and four out of 5 older women attend, despite screening being one of the best defences against cervical cancer. GynaeCheck uses state-ofthe-art technology, ensuring the highest levels of HPV detection possible, and offers comfortable home collection of samples so there is no excuse for not getting tested. GynaeCheck+ which will also test for Chlamydia is also available.

GynaeCheck Procedure GynaeCheck is carried out in the comfort and privacy of the home. Upon sign-up the GynaeCheck test kit is sent out in the post. The kit – including collection device and transport vial – contains full, simple instructions and a pre-paid return envelope. Within 10 days of returning the sample, employees will receive

We can deliver a 40 minute presentation plus questions by an experienced clinician focused on cervical cancer and covering symptoms, risk reducing steps and treatment options. A copy of the presentation and My Cervical Health brochure will be available as hand-outs. Optimal group size is up to 40. GynaeHealth UK can provide copy material for client’s intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can the co-branded for a campaign.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard prices. The cost of GynaeCheck under salary sacrifice starts at £4.50 per month. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service provided.

Who will benefit • GynaeCheck is for all women aged 25+ • Women who do not participate in national cervical screening programme • All women will benefit from greater understanding of HPV

To enquire 0800 085 6663 10

Info@Check4Cancer.com

www.Check4Cancer.com


The majority of people with the early stages of lung cancer have no apparent symptoms Lung cancer is the second most common cancer among men in the UK, and the third most common cancer among women. Whilst the overall number is declining, it is on the increase in women and there are still 41,000+ lung cancers diagnosed each year in the UK.

LungCheck 80% of all lung cancers are directly or indirectly connected with smoking – but 1 out of 7 lung cancers are diagnosed in people who have never smoked. There is no national screening programme for lung cancer. There are clinical trials evaluating low dose CT scans, but CT scans are less specific than LungCheck and will identify a high number of clients with abnormal results who do not actually have the disease (false positives). CT scanning is also more expensive than LungCheck.

LungCheck Procedure An online symptomatic score and lung cancer risk assessment is undertaken, based on lifestyle, symptoms and family history. This is followed by a unique blood test (EarlyCDT® – Lung) which is more accurate than CT scanning, and seven times more likely to correctly identify lung cancer. Within 4-6 weeks of the appointment, employees will receive a results letter and a personalised early detection programme. Should they be considered at high risk, they will be referred to a respiratory consultant for further assessment and investigation. All abnormal test results clients will get FREE CT scan and consultation with respiratory consultant.

If on-site clinics are not available LungHealth UK will be able to access fit for purpose private clinics from more than 80 in our network throughout the United Kingdom and other countries upon request.

Lung Health Awareness We can deliver a 40 minute presentation plus questions by an experienced clinician focused on lung cancer and covering symptoms, risk reducing steps and treatment options. A copy of the presentation and My Lung Health brochures will be available as hand outs. Optimal group size is up to 40. LungHealth UK can provide copy material for client intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can be co-branded.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard pricing. A typical taxpayer will pay around £17 per month under salary sacrifice. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service offering.

Clinic locations LungCheck may be available through an in-company clinic, a clinic close to the workplace or in a private hospital close to home or work. Alternatively, Check4Cancer can guide your staff how best to get their GP surgery to do the blood sample. Check4Cancer will organise the logistics and ensure the process is as painless as possible for your staff. On-site clinics are generally the most cost effective solution. We will require:

• Access to the internet • Couch • Wash hand basin

Who will benefit

• Employees who are current and past heavy smokers • LungCheck* is suitable for men and women from the age of 40 • Available to smokers or ex-smokers from the age of 40

To enquire 0800 085 6663

Info@Check4Cancer.com

www.Check4Cancer.com 11


Over 40,000 men are diagnosed with prostate cancer each year In this year alone, more than 10,000 men will die of prostate cancer. Nearly half of all men are expected to get the disease at some stage in their life. The chances of survival are nonetheless extremely high in those whose tumours are diagnosed when there are few symptoms, and when the disease is confined to the prostate gland.

ProstateCheck There is no national prostate cancer early detection programme in the UK and it is unlikely that one will be introduced in the near future. There are mixed opinions on the effectiveness of early detection programmes. The standard test for early detection of prostate cancer is for PSA (Prostate Specific Antigen), which can lead to unwarranted further investigations. With the introduction of ProstateCheck, however, 30-50% of all unnecessary biopsies can be eliminated.

ProstateCheck Procedure ProstateCheck comprises an online symptomatic score and prostate cancer risk assessment based on lifestyle, symptoms and family history, followed by a blood test, which will give unique feedback on 4 biomarkers (if PSA is increased). Within 1-2 weeks of the appointment we issue the result letter and personalised early detection programme. Should any employee be considered at high risk, they will be referred to a their GP or a consultant urologist for further assessment and investigation. For men with an elevated PSA the results letter will also identify their risk of getting a high grade tumour, which will help clinicians to reduce the number of unnecessary biopsies by 30-50%.

If on-site clinics are not available ProstateHealth UK will be able to access fit for purpose private clinics from more than 80 in our network throughout the United Kingdom and other countries upon request.

Prostate Health Awareness We can deliver a 40 minute presentation plus questions by an experienced clinician focused on prostate cancer covering symptoms, self-awareness, risk reducing steps and treatment options. A copy of the presentation and My Prostate Health brochures will be available as handouts. Optimal group size is up to 40. ProstateHealth UK can provide copy material for client intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can be co-branded.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard pricing. A typical taxpayer will pay around £8 per month under salary sacrifice. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service offering.

Clinic locations ProstateCheck may be available through an in-company clinic, a clinic close to the workplace or in a private hospital close to home or work. Alternatively, Check4Cancer can guide your staff how best to get their GP surgery to do the blood sample. Check4Cancer will organise the logistics and ensure the process is as painless as possible for your staff. On-site clinics are generally the most cost effective solution. We will require:

• Access to the internet • Couch • Wash hand basin

Who will benefit

• Men of all ages will benefit from a greater understanding of prostate cancer • ProstateCheck is suitable for men over 40 • Men with family history

To enquire 0800 085 6663 12

Info@Check4Cancer.com

www.Check4Cancer.com


Skin cancer is one of the most common cancers affecting both men and women There are more than 100,000 cases every year, and over 2,800 lives lost. UV rays from the sun or sun beds are the biggest cause, with the use of sun beds doubling the risk.

SkinCheck and SkinCheck+ The government is not planning to introduce any national skin screening programmes, but a Health and Safety report from the TUC outlines employers’ responsibilities for skin cancer prevention and encourages them to help exposed and high-risk employees to understand skin cancer, its symptoms and how to be skin aware. Despite the majority of moles being normal, a small number undergo change into melanoma. Identifying these changes as early as possible can save lives. A complete SkinCheck examination assesses all moles and lesions (including the back). Anything unusual will be analysed using the latest technology and reported by leading national experts.

SkinCheck+

As an optional add-on, SkinHealth UK can now offer skin analysis using UV Reader to analyse facial skin. This gives even more accurate feedback on skin damage and helps suggest ways to tackle or avoid it.

SkinCheck Procedure SkinCheck involves an online risk assessment examining the personal risk of skin cancer, followed by a 20 minute consultation comprising a review of the risk assessment, a complete skin examination using Dermoscopy (looking deep into the layers of the skin) and tuition in what to look out for. Within 5 days of the appointment we issue a lesion-by-lesion results letter and personalised early detection programme. Should an employee be considered high risk, they will be referred to their GP or a consultant dermatologist or plastic surgeon for further assessment and investigation.

Clinic locations SkinCheck may be available through an in-company clinic, a clinic close to the workplace or in a private hospital close to home or work. On-site clinics are generally the most cost effective solution. We will require:

• Access to the internet • Access to a printer • Couch • Wash hand basin If on-site clinics are not available SkinHealth UK will be able to access fit-for-purpose private clinics from more than 80 in our network throughout the United Kingdom and other countries upon request.

Skin health awareness We can deliver a 40 minute presentation plus questions by an experienced clinician focused on skin cancer and covering symptoms, risk reducing steps and treatment options. Copies of the presentation and My Skin Health brochures will be available as hand outs. Optimal group size is up to 40. SkinHealth UK will also provide service specific brochures. At each appointment employees will be given a sunscreen sample and a leaflet explaining how to minimise the risk of skin cancer. SkinHealth UK can provide copy material for client intranet sites, posters, banners and table tents. We can also design and provide client specific websites which can be co-branded.

Prices By offering these services to its staff, an employer can achieve up to 25% discount on standard pricing. A typical taxpayer will pay around £6 per month under salary sacrifice. For company sponsored campaigns, prices are negotiable depending on company size and the extent of the service offering.

Who will benefit

• All employees will benefit from this service • SkinCheck is suitable for men and women • All ages. Skin cancer is the most common cancer in the 15 to 35 years age group • Outdoor workers are twice as likely to contract skin cancer as their indoor colleagues.

To enquire 0800 085 6663

Info@Check4Cancer.com

www.Check4Cancer.com 13


Who We Work With Check4Cancer works with a growing number of employers. The organisations who have introduced our services to their employees include:

Please visit https://www.check4cancer.com/who-we-work-with for further details.

14


Case study: Hewlett Packard’s four major cancer campaigns In September 2011, HP launched their global breast awareness and screening campaign – The Power of Pink – involving over 100,000 employees across the US and Europe. Cambridge-based Check4Cancer was chosen to work with HP in the UK, Sweden and Denmark. So successful was it that HP followed up with equivalent campaigns targeting prostate cancer, skin cancer and lung cancer. HP set out with four key objectives: to raise awareness of cancer throughout the entire workforce; to ensure that people understood their own risk, via personal online assessment; to provide education, running a number of sessions across HP sites using specialists, and to identify cancers through a corporate screening programme. This was paid for by the company itself, and was offered not only to employees, but also spouses and partners of employees. 148 women were referred from BreastCheck as a result the Power of Pink campaign, of which two cancers were diagnosed following further investigation. HP followed this up with a prostate campaign, entitled “Be a Hero”, launched by Nick Wilson, UK CEO of HP. 3,087 men aged 40+ chose to have ProstateCheck, and 484 considered at high risk were referred for further investigation. More significantly, 12 cases of prostate cancer were identified that would have gone undetected without the “Be a Hero” campaign. Next, HP took the decision to invest in a campaign for skin cancer for the HP community in the UK. The campaign, called “Detect & Protect”, was launched in May – the time when people are most likely to notice changes in their skin as they prepare for summer – and SkinCheck was delivered almost entirely onsite. 3,020 HP employees chose to have SkinCheck, with 100% of all available appointments being taken up. Eight cases of skin cancer were identified, including two melanomas that would have gone undetected.

The “Love Your Lungs” lung cancer campaign followed. 2,503 employees chose to have LungCheck. 124 employees of these had abnormal lung health and were referred for further investigation. In total, around 10,000 employees were screened – about 27% of the eligible population. Within that, the prostate and breast cancer campaigns reached over 40% of the eligible workforce. From these early detection programmes, over 1,000 cases were referred for further investigation. These ultimately resulted in at least 65 cancers being detected early amongst employees or their partners. It was noted that within these were a handful of cases that had been missed by NHS screening. Feedback showed that 93% of those taking part rated the experience as excellent, and there were numerous anecdotal cases of employees expressing gratitude for what the company had done for them. The campaigns attracted awards for the company, including the Employee and Healthcare award in 2013, and a ‘Business In The Community’ award in 2014. Ultimate recognition came from employees, however, with one woman – whose breast cancer was detected early – stating: “I really believe working for HP saved my life”.

“To manage the health risk of employees in such a structured, consistent and targeted way is a model that, I think, will be followed by other employers in the future. It will lend itself to academic research into greater risk stratification and more targeted intervention. HP is to be congratulated for taking such an interest in not just their employees, but also their families, supporting as it does, ‘Improving Lives’, the government's National Strategy on Cancer.” Professor Gordon Wishart, Medical Director, Check4Cancer

15


Case study: Mazars – cancer screening as a benefit

Mazars – the global audit, accounting and consulting group – expanded its 2014/15 flex-plan by teaming up with Check4Cancer to provide cancer specific screening for its 1,400 UK employees and subsequently have offered the product as a benefit to their own clients. For Mazars, there was a graphic demonstration of the value of cancer screenings in the very first stages of their involvement. Richard Stewart, Head of Flexible Benefits and Platform Services at Mazars says: “We met with the company several times, then agreed to trial it internally, so had several people go and have tests done and get the results back. One of those did pick up something, which was quite an eye-opener.” From there, Mazars made cancer checks available to their own employees under a new benefit scheme. Beneficial though this service clearly is to the employee, Richard is keen to point out that it did not simply fall into the category of CSR – it was about saving lives and saving money. “From our perspective, there’s no point in doing this unless, from a value proposition point of view, it works. There are three elements to the value proposition for the health screening: first the employer subsidises it, second it is tax exempt, and third there’s a corporate discount that makes it super-valuable to an employee interested in looking after their health.” Another positive factor for Mazars was that consultations took place in the workplace wherever possible, offering minimum inconvenience and maximum flexibility for the employee, which in turn reduced disruption of workflow and minimised potential downtime. It also offered those employees something distinct and new as a benefit, which was clearly of value to them.

16

“The structure of the screening service was very attractive to us. It’s delivered at a much lower price than a traditional screen, and not duplicating what they could get at their GP’s surgery for free. But it is also broken down into different areas so you could opt to have a screen for prostate cancer one year, then move on to another one the next.” The success of cancer screening as a benefit among Mazars’ own employees naturally led to the company offering them to their own client market – a clear stamp of approval for the service. “Our clients are always interested in ways to help their employees’ proposition and the relationships they have with them, and if those companies have suffered or are suffering from large cancer-related claims, then this offers them an alternative which helps them, but also has the potential to save the employee from a later stage diagnosis. This is why we like the product.”

“All the pricing and tax boxes get ticked, but at the end of the day it’s also a really important thing. We’ve already seen it in our trials; if something gets an early indication that something is not right, that is life-changing for that person, so it’s not difficult to become passionate about this. This is a real way of helping fight cancer.” Richard Stewart, Head of Flexible Benefits and Platform Services, Mazars


Case study: Lend Lease – tackling a specific threat Between May and August 2014, Lend Lease – a world-leading international property and infrastructure group – offered a skin cancer screening programme for 1,200 employees in its EMEA arm in partnership with Check4Cancer. Due to the nature of the business, which involves very large scale building projects, a large proportion of Lend Lease employees work outside on construction sites. This, in turn, means prolonged exposure to sunlight, but an in-house survey had revealed that 52% of employees did not use protection against the effects of the sun. The challenge on this occasion was to help raise awareness of this issue and to offer skin cancer check programme. According to figures from Cancer Research UK, there were more than 100,000 cases of skin cancer diagnosed in the UK in 2012, with 2,148 deaths from malignant melanoma skin cancer and 638 deaths from non-melanoma skin cancer. 86% of malignant melanoma skin cancer cases each year in the UK are linked to major lifestyle and other risk factors. Figures from the Health & Safety Executive indicate that in the near future exposure to solar radiation will become one the main causes of occupational cancer. Employees were offered a SkinCheck, with sign-up on a firstcome, first-served basis, and those booked for appointments completed a risk assessment survey based on lifestyle, family history and skin type. Initially, the company offered 200 screening slots, but demand was so high that the company immediately doubled this figure – and in 2015 intend to double it again, offering 800 slots. Checks were offered free, funded by the company, and timed to take place in spring and early summer – prior to summer holidays. 30-minute consultations with a skin specialist nurse followed, comprising a review of the risk assessment, examination of the skin, and further advice on self-examination. The checks took place on Lend Lease premises all over the UK, and in its Milan

office in Italy, conducted in designated meeting rooms and Portakabin offices on the construction sites themselves. Any suspicious mole or lesion was photographed and reported on by SkinHealth UK clinical lead, Mr Per Hall, of Addenbrooke’s Hospital, Cambridge, and his team. Results letters were sent out within 3-5 days, and any client with a mole or lesion that required further investigation was informed of their referral options. 10% of those tested were referred for further checks. Gemma Bourne, Head of Social Sustainability and Lend Lease Foundation (Europe) described feedback from employees as “absolutely fantastic”. Accessibility of the checks at the place of work – which meant no travel was required and downtime was minimised – proved a major positive factor, and was instrumental in generating such high levels of uptake. It is now a regular benefit offered to employees at Lend Lease.

“One of my colleagues had a tiny mole on the sole of his foot which he had to have removed. He never would have caught that – he didn’t even know it was there. That consultation effectively saved his life.” Gemma Bourne, Head of Social Sustainability and Lend Lease Foundation (Europe)

17


Client Satisfaction

Over 1,700 Check4Cancer clients have taken the time to provide their feedback, with 93% rating their experience as ‘excellent’ or ‘very good’. “I feel so very lucky that my cancer was diagnosed very early on, and I dread to think what could have happened if I had not had the BreastHealth UK screening at work which resulted in me having the biopsy, it could so easily have gone undiagnosed for a lot longer.”

Marisa, Employee, Hewlett-Packard

and tax boxes get ticked, but at the end of the day it’s also a really important thing. We’ve already seen it in our trials; if something gets an early indication that something is not right, that is life-changing for that person, so it’s not difficult to become passionate about this. This is a real way of helping fight cancer.”

Richard Stewart, Head of Flexible “It was a pleasure working with you and your team; Benefits and Platform Services at Mazars a team who care about what they do and work so hard to make everything work as well as it does. I look forward to working with you again.”

Nigel Freestone, Campaign Site Ambassador, Hewlett-Packard “I was very impressed with the professionalism and personal treatment I received when visiting the clinic. I have to admit I was slightly nervous but was quickly put at ease. Afterwards the results arrived very quickly and I was just relieved I hadn’t put my SkinCheck off any longer.”

Lynn Jones, Human Resources Director, Executive Offices Group “This is why we like the product.“All the pricing

18

“In total, 35% of our employees had the checks, part way through we had to double the number available as demand was so high”

Gemma Bourne, Head of Social Sustainability and Lend Lease Foundation (Europe)


Presentation feedback

Statistics provided by Zurich Insurance following a series of presentations by Check4Cancer.

19


Employees at increased risk

The Health and Safety Executive estimates there are now 13,500 new cases of occupational cancer each year, with over 8,000 deaths. The TUC estimates over 20,000 new cases with over 15,000 deaths. While some environmental risk factors have been widely publicised for a number of years – exposure to asbestos, for example – others are less well-known. Shift work, for example, is now classified as a Group 2A carcinogen (probably carcinogenic to humans). A number of recent publications have suggested that rates of several types of cancer may be increased in people who work irregular shifts, or those who work as flight attendants, suggesting that rapid and irregular changes in body clock may play a role in the development of certain cancers. The International Agency for Research on Cancer recently designated shift work that involves disruption of biological rhythms as a probable cause of human cancer. The evidence is strongest for breast cancer, where a systematic review suggested that such occupational factors might increase the risk by 50% and where in Denmark compensation is now payable to women who have worked night shifts over a prolonged period.

20

30% of women now have a shift pattern that involves night work.


Night shift workers have 51% increased breast cancer risk

Night shift work and breast cancer As well as the established risk factors for breast cancer, a number of environmental and occupational risk factors have been identified including radiation, exposure to chemicals including organochlorines and pesticides and shift work. During the last 20 years there has been a significant rise in female shift work, and 30% of women now have a shift pattern that involves night work. It has been recognised for some time that exposure to light at night alters circadian (biological) rhythms that lead to genetic changes in key cancer pathways. It is now thought that up to 5% of all breast cancer cases are caused by night shift work. In the UK, with nearly 50,000 newly diagnosed cases per annum, this means that up to 2,500 new cases each year are being caused by an avoidable risk factor.

Night shift work and prostate cancer A recent study of over 3,000 men who regularly carried out night work showed a significantly increased risk for lung, prostate, bladder and colon cancer. Clearly some additional factors such as cigarette smoking might be more common in night workers, but are unlikely to explain the doubling of risk for prostate cancer which was found in this study. Two other studies found an increase in prostate cancer in night workers, and one did not. The incidence of prostate cancer is strongly related to awareness of the condition and national screening programmes for prostate cancer based on testing for Prostate Specific Antigen (PSA). However, the evidence is now growing that working at night for prolonged periods may significantly increase the risk of prostate cancer.

This information is extracted from medical papers on occupational cancer risk written by three of Check4Cancer’s clinical advisors: ‘Night shift workers have 51% increased breast cancer risk’ & ‘Flight personnel have 44% increased breast cancer risk’ by Prof. Gordon. C. Wishart (Clinical Advisor – Breast) ‘Increased risk of prostate cancer risk in men who work night shifts’ by Prof. David Neal (Clinical Advisor – Prostate) ‘Flight personnel have 2-3 times increased risk of skin cancer’ by Mr Per Hall (Clinical Advisor – Skin) These papers can be read in their entirety at www.Check4Cancer.com 21


Employees at increased risk

Flight personnel have 2-3 times increased risk of skin cancer

Flight personnel and breast cancer risk

Flight personnel and skin cancer risk

A number of studies have shown that flight personnel have an increased risk of breast cancer, and possible contributing factors include shift work and exposure to ionising radiation. In the recent publication, a meta-analysis of studies in flight personnel has shown an increased risk of 44%, increasing the average breast cancer risk to 18%. The increased figure of 44% is very similar to the increased risk for night shift work (51%) suggesting that this may be the most important contributing factor for flight personnel. Of course, not all women have an average breast cancer risk. Some women may have a baseline lifetime risk as high as 30%. For these women, an additional risk factor – such as working as flight personnel for a number of years – may increase their risk to as high as 43%.

Two studies were published in 2006 looking into all the research and drawing it all together (called a meta analysis). Both studies found a 2-3 times increase in the risk of melanoma in female flight personnel without identification of any specific risk factor(s). Researchers from Scandinavian countries also evaluated data from 10,000 male airline pilots over 17 years. Skin cancer was three times more likely to occur in these pilots than the general population. Possible occupational exposures include ionizing radiation and recreational exposure to the sun during off duty hours. Regardless of the cause, education and awareness of the risks and how to minimise them would be good practice in this group and should be encouraged by their employers.

22


Payment Options and Pricing Employers can provide our services to their employees in a number of different ways: 1. Flexible Benefits /Salary Sacrifice - where prices for employees start from as little as £4 a month net of tax and national insurance. 2. Company paid – where employers fund the full costs of our services and are able to achieve a 25% discount on standard pricing 3. Voluntary Benefits – discounts are available depending on the size of the employee population 4. Cash Plans – where cash plans provide health screening cover, employees can use this benefit to cover the cost of our screenings subject to each cash plan provider’s terms and conditions. All our screening services are VAT exempt. There are a number of pricing variables including number of employees, clinic options and location. We can only provide a comprehensive quotation following a detailed discussion. The lowest cost option for employers is where we can deliver our clinics on-site. If you cannot find the information you are looking for then please get in touch and we will be happy to answer any questions you may have. You can contact us on 0800 085 6663 or email our Managing Director, Troels Jordansen at Troels@Check4Cancer.com

23


Contact us If you are an employee and would like to make a booking or have any questions please call our friendly team on 0800 085 6663 between 09.00 and 16.30. Calls are treated in the strictest confidence. You can also contact us by e-mail at Info@Check4Cancer.com or reach us by fax on 01223 281316. If you are an employer enquiring about Check4Cancer services please contact Troels Jordansen at Troels@Check4Cancer.com If you would like to write to us, our address is: Check4Cancer 1 The Mill Copley Hill Business Park Cambridge Road Cambridge CB22 3GN Check4Cancer is the trading name of Check4Cancer Ltd Registered address as above. Company Number 088866941

Sacrificing Salary to Save Lives  
Read more
Read more
Similar to
Popular now
Just for you